Literature DB >> 3741832

Orbital mucormycosis with survival.

M O'Keefe, W M Haining, J D Young, W Guthrie.   

Abstract

Orbital mucormycosis is reported in a healthy patient with maturity onset diabetes who was treated with orbital exenteration, amphotericin B, and ketoconazole. A six-year follow-up shows no evidence of recurrence.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3741832      PMCID： PMC1040787          DOI： 10.1136/bjo.70.8.634

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  7 in total

1.  Acute orbital mucormycosis. Report of two cases.

Authors:  J D GASS
Journal:  Arch Ophthalmol       Date:  1961-02

2.  Cerebral mucormycosis; report of a case.

Authors:  H H GUNSON; D H BOWDEN
Journal:  AMA Arch Pathol       Date:  1955-10

3.  Two cases of orbital phycomycosis with recovery.

Authors:  J D Bullock; L M Jampol; A J Fezza
Journal:  Am J Ophthalmol       Date:  1974-11       Impact factor: 5.258

4.  Lethal orbito-cerebral phycomycosis in otherwise healthy children.

Authors:  F C Blodi; F T Hannah; J A Wadsworth
Journal:  Am J Ophthalmol       Date:  1969-05       Impact factor: 5.258

5.  Rhino-orbital mucormycosis occurring in an otherwise apparently healthy individual.

Authors:  J L Baum
Journal:  Am J Ophthalmol       Date:  1967-02       Impact factor: 5.258

6.  Laboratory and clinical assessment of ketoconazole in deep-seated mycoses.

Authors:  E Drouhet; B Dupont
Journal:  Am J Med       Date:  1983-01-24       Impact factor: 4.965

7.  Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases.

Authors:  J H Lewis; H J Zimmerman; G D Benson; K G Ishak
Journal:  Gastroenterology       Date:  1984-03       Impact factor: 22.682
  7 in total
  4 in total

1.  Diabetes mellitus, fever, proptosis, and rapid loss of vision.

Authors:  R Goswami; N Tandon; S Thulkar; N Kochupillai
Journal:  Postgrad Med J       Date:  1996-10       Impact factor: 2.401

2.  In vitro susceptibility to 9 antifungal agents of 14 strains of Zygomycetes isolated from clinical specimens.

Authors:  M Otcenásek; V Buchta
Journal:  Mycopathologia       Date:  1994-12       Impact factor: 2.574

3.  Acute proptosis and blindness in a patient with orbital phycomycosis.

Authors:  R C Humphry; G Wright; W J Rich; R Simpson
Journal:  J R Soc Med       Date:  1989-05       Impact factor: 18.000

4.  Orbital mucormycosis in an immunocompetent individual.

Authors:  P Badiee; Z Jafarpour; A Alborzi; P Haddadi; M Rasuli; M Kalani
Journal:  Iran J Microbiol       Date:  2012-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.